ストックスクリーナーアプリを入手
20.39
0.02%
-0.0597
Xencor Inc (XNCR) 最新ニュース
Down -21.69% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround - Yahoo Finance
JPMorgan Chase & Co. Acquires 3,635 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR) - Yahoo Finance
Xencor (NASDAQ:XNCR) Stock Price Down 3.8%What's Next? - MarketBeat
Xencor Becomes Oversold (XNCR) - Nasdaq
Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know - MSN
Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks - Yahoo Finance
Xencor (NASDAQ:XNCR) Trading Down 9.3%Here's Why - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
How To Trade (XNCR) - Stock Traders Daily
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Principal Financial Group Inc. - Defense World
Is Xencor (NASDAQ:XNCR) Using Too Much Debt? - Simply Wall St
(XNCR) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
26,831 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Sanctuary Advisors LLC - Defense World
Sanctuary Advisors LLC Takes $540,000 Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Barclays PLC Raises Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Barclays PLC Increases Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Intrahepatic Cholangiocarcinoma Pipeline Insights 2024: Therapies, Clinical Trials, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapeutics - The Globe and Mail
Fmr LLC Buys 12,729 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Jane Street Group LLC - MarketBeat
State Street Corp Reduces Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
When (XNCR) Moves Investors should Listen - Stock Traders Daily
Xencor (NASDAQ:XNCR) Earns Overweight Rating from Analysts at Wells Fargo & Company - Defense World
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Xencor's SWOT analysis: biotech stock balances promise and challenges - Investing.com
Xencor's SWOT analysis: biotech stock balances promise and challenges By Investing.com - Investing.com Canada
Wells Fargo Initiates Coverage of Xencor (XNCR) with Overweight Recommendation - MSN
All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy - MSN
Xencor (NASDAQ:XNCR) Now Covered by Wells Fargo & Company - MarketBeat
Rockefeller Capital Management L.P. Invests $205,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
The Manufacturers Life Insurance Company Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Charles Schwab Investment Management Inc. Has $12.61 Million Holdings in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
(XNCR) Technical Pivots with Risk Controls - Stock Traders Daily
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
46,700 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Polar Asset Management Partners Inc. - MarketBeat
Readystate Asset Management LP Buys New Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet - MSN
RTW Investments LP Takes $11.56 Million Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
RA Capital Management L.P. Makes New Investment in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Point72 Asset Management L.P. Purchases 1,858,440 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Xencor director Montgomery sells $397,930 in stock - Investing.com India
Xencor director Montgomery sells $397,930 in stock By Investing.com - Investing.com Canada
Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight - Law360
Piper Sandler Upgrades Xencor (XNCR) - MSN
Xencor, Inc.'s (NASDAQ:XNCR) 26% Share Price Surge Not Quite Adding Up - Simply Wall St
Xencor stock hits 52-week high at $26.89 amid robust gains - Investing.com Canada
1.07%
8.16%
大文字化:
|
ボリューム (24 時間):